Low Dose Oral and Transdermal Therapy of Hypertension

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology
Cover of the book Low Dose Oral and Transdermal Therapy of Hypertension by , Steinkopff
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783642537851
Publisher: Steinkopff Publication: April 17, 2013
Imprint: Steinkopff Language: English
Author:
ISBN: 9783642537851
Publisher: Steinkopff
Publication: April 17, 2013
Imprint: Steinkopff
Language: English

This book brings together papers presented at an international symposium on centrally­ acting antihypertensive agents held in Geneva, Switzerland, in association with the 10th Scientific Meeting of the International Society of Hypertension. A major focus of this symposium was the sympatholytic agent, clonidine, and was partly stimulated by the re­ cent development of an innovative transdermal system for administering this antihyper­ tensive drug. Although clonidine has been available to clinicians for several years, there has been a re­ cent reawakening of interest in this type of medication. The centrally-acting antihyper­ tensive agents appear to be effective both as monotherapy and in combination with other drugs. There are no significant contraindications to their use, and they do not appear to produce metabolic side effects. In this symposium we have paid attention to two types of patients: those with uncomplicated mild hypertension, and those with more difficult forms of hypertension associated with concurrent conditions.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book brings together papers presented at an international symposium on centrally­ acting antihypertensive agents held in Geneva, Switzerland, in association with the 10th Scientific Meeting of the International Society of Hypertension. A major focus of this symposium was the sympatholytic agent, clonidine, and was partly stimulated by the re­ cent development of an innovative transdermal system for administering this antihyper­ tensive drug. Although clonidine has been available to clinicians for several years, there has been a re­ cent reawakening of interest in this type of medication. The centrally-acting antihyper­ tensive agents appear to be effective both as monotherapy and in combination with other drugs. There are no significant contraindications to their use, and they do not appear to produce metabolic side effects. In this symposium we have paid attention to two types of patients: those with uncomplicated mild hypertension, and those with more difficult forms of hypertension associated with concurrent conditions.

More books from Steinkopff

Cover of the book Cardiac Disease in the Elderly by
Cover of the book Predisposing Conditions for Acute Ischemic Syndromes by
Cover of the book Cardiovascular Magnetic Resonance by
Cover of the book Current Problems in PTCA by
Cover of the book Current Topics in Heart Failure by
Cover of the book Pathophysiology and Rational Pharmacotherapy of Myocardial Ischemia by
Cover of the book ESWT and Ultrasound Imaging of the Musculoskeletal System by
Cover of the book Risk and Protective Factors in Schizophrenia by
Cover of the book Search for the Causes of Schizophrenia by
Cover of the book Arteriosclerosis by
Cover of the book Lung Transplantation by
Cover of the book Angiotensin and the Heart by
Cover of the book Acute Pulmonary Embolism by
Cover of the book Cardiac Pacemakers by
Cover of the book Interventional Cardiology and Angiology by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy